The Pap smear hunts cervical cell changes before cancer spreads
A Pap test samples cells from the cervix’s transformation zone to catch precancerous or cancerous change—and, more rarely, anal cells. Guidelines usually start screening in the early twenties and repeat every three to five years if results stay normal.
A clinician opens the vagina with a speculum and gathers cells with an Ayre spatula or cytobrush where squamous and glandular tissues meet. Abnormal results may mean a repeat in six to twelve months or further workup, depending on the finding. Under the microscope, examiners look for dysplasia, also labelled CIN or SIL, caused by human papillomavirus, a DNA virus passed on sexually. The smear can sometimes spot trouble higher in the endocervix or endometrium, but it was never built for that. After a hysterectomy that removed the cervix, the smear is usually unnecessary.
ACOG and some U.S. groups start at twenty-one; parts of Britain wait until twenty-five; many systems continue until about fifty or sixty. Older annual schedules lack strong evidence once intervals of three to five years work for people without prior abnormalities. Closer scrutiny can mean colposcopy, which magnifies the cervix, vagina and vulva, or HPV DNA testing; some countries now test for viral DNA before looking at cells at all. ACOG advises yearly well-woman visits between 30 and 65 but smears only every three to five years.
Human papillomavirus spreads by skin contact, not only intercourse, and immune clearance averages about a year, sometimes up to four. Testing during that window often picks up the body's repair work as mild abnormalities that rarely lead to cancer but can trigger worry, more tests and even treatment. Because cervical cancer develops slowly, starting a few years later carries little risk; screening under-25s has not lowered cancer rates before age 30. People who have sex only with women still need screening, though cervical cancer risk is somewhat lower.
The method carries the name of Georgios Papanikolaou, the Greek physician who developed it in the 1920s, and the Canadian obstetrician Anna Marion Hilliard introduced a simpler version in 1957.
Source: Pap test
